Table 1.

Effect of DI-TSP peptide on FGF-2 binding to TSP-1 and on FGF-2 interaction with the matrix


Condition

Concentration

Inhibition of FGF-2 binding to TSP-1, % of control

Inhibition of FGF-2 binding to ECM, % of control

Mobilization of matrix-bound FGF-2, % of bound FGF-2
Vehicle   —   100.0 ± 6.0   100.0 ± 3.3   29.6 ± 0.3  
TSP-1   100 nM   13.7 ± 6.5   14.8 ± 2.3   74.0 ± 1.2  
DI-TSP   10 μM   90.0 ± 3.2   104.0 ± 6.4   30.4 ± 0.3  
DI-TSP   1 μM   84.0 ± 1.7   104.1 ± 1.0   NT  
DI-TSP
 
100 nM
 
87.0 ± 21.1
 
101.4 ± 6.4
 
NT
 

Condition

Concentration

Inhibition of FGF-2 binding to TSP-1, % of control

Inhibition of FGF-2 binding to ECM, % of control

Mobilization of matrix-bound FGF-2, % of bound FGF-2
Vehicle   —   100.0 ± 6.0   100.0 ± 3.3   29.6 ± 0.3  
TSP-1   100 nM   13.7 ± 6.5   14.8 ± 2.3   74.0 ± 1.2  
DI-TSP   10 μM   90.0 ± 3.2   104.0 ± 6.4   30.4 ± 0.3  
DI-TSP   1 μM   84.0 ± 1.7   104.1 ± 1.0   NT  
DI-TSP
 
100 nM
 
87.0 ± 21.1
 
101.4 ± 6.4
 
NT
 

Labeled FGF-2 was incubated with immobilized TSP-1 alone (vehicle) or in the presence of soluble TSP-1 or DI-TSP peptide, used as competitors, as described. 31  Data are the percentage of control binding, without competitors (vehicle). The ability of TSP-1 and DI-TSP peptide to affect FGF-2 binding to the matrix and to mobilize FGF-2 from the matrix were assayed as described in “Materials and methods.”—indicates not applicable; NT, not tested.

or Create an Account

Close Modal
Close Modal